by Waqas Tariq | May 18, 2019 | News Archive
Austrianova signed an MOU on future collaboration with TCELS during BIO 2018 in Boston on 8th June
by Waqas Tariq | May 18, 2019 | News Archive
SG Austria/Austrianova announces on 28th March it has just been awarded “Best Life Science Service Company” by APAC Insider Magazine
by Waqas Tariq | May 18, 2019 | News Archive
John Dangerfield was an invited guest speaker giving the presentation on “Cell-in-a-Box® Live Cell Encapsulation: A Platform Technology For Delivery Of Therapeutic Antibodies” at the 5th Antibody Symposium in Singapore on March 5th 2018”
by Waqas Tariq | May 18, 2019 | News Archive, Uncategorized
John Dangerfield, Austrianova’s COO, gave an invited presentation at the Stem Cell Society Singapore’s (SCSS) Symposium 2017 on 17th November 2017
by Waqas Tariq | May 18, 2019 | News Archive, Uncategorized
Austrianova’s CEO, Dr. Brian Salmons, attended BIO-Europe 6-8 November 2017 in Berlin as part of the Thai delegation
by Waqas Tariq | May 18, 2019 | News Archive, Uncategorized
Austrianova was named L’Oreal’s Innovation Runway Start-up Challenge 2017 winner at the SWITCH TechInnovation event at the Marina Bay Sands Expo and Convention Centre in Singapore.
by Waqas Tariq | May 18, 2019 | News Archive, Uncategorized
A Chinese research group has reported in the journal PLoS ONE the use of Cell-in-a-Box to encapsulate dermal and epidermal cells for successful hair follicle reconstruction in animal...
by Waqas Tariq | May 18, 2019 | News Archive, Uncategorized
Austrianova attended BIO in San Diego with TCELS as part of the Thai Delegation
by Waqas Tariq | May 18, 2019 | News Archive, Uncategorized
Austrianova Chairman and CTO, Walter H. Gunzburg, was an invited participant in the 2nd ‘Voice of the Researchers’ dialogue platform, co-hosted by EURAXESS ASEAN and the European Union Delegation to Singapore. ‘Voice of the Researchers’ is a...
by Waqas Tariq | May 18, 2019 | News Archive, Uncategorized
Austrianova attended BioPharma Asia 2017 in Singapore on March 22-23, a networking event that brings 2,000 pharma and biotech representatives together with regulators, policy makers and innovative solution providers.
